Kenneth Bate - Net Worth and Insider Trading
Kenneth Bate Net Worth
The estimated net worth of Kenneth Bate is at least $295,841 dollars as of 2024-09-20. Kenneth Bate is the Director of Madrigal Pharmaceuticals Inc and owns about 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $290,216. Kenneth Bate is also the Director of AVEO Pharmaceuticals Inc and owns about 375 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $5,625. Details can be seen in Kenneth Bate's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Bate has not made any transactions after 2024-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Bate
Kenneth Bate Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Bate owns 8 companies in total, including Genocea Biosciences Inc (GNCAQ) , Madrigal Pharmaceuticals Inc (MDGL) , and Astria Therapeutics Inc (ATXS) among others .
Click here to see the complete history of Kenneth Bate’s form 4 insider trades.
Insider Ownership Summary of Kenneth Bate
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GNCAQ | Genocea Biosciences Inc | 2014-09-11 | director |
MDGL | Madrigal Pharmaceuticals Inc | 2024-04-02 | director |
ATXS | Astria Therapeutics Inc | 2015-06-24 | director |
2016-05-26 | director | ||
2019-05-31 | director | ||
2017-06-15 | director | ||
2010-09-22 | director | ||
2014-09-11 | director |
Kenneth Bate Latest Holdings Summary
Kenneth Bate currently owns a total of 2 stocks. Among these stocks, Kenneth Bate owns 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) as of April 2, 2024, with a value of $290,216 and a weighting of 98.1%. Kenneth Bate also owns 375 shares of AVEO Pharmaceuticals Inc (AVEO) as of March 11, 2010, with a value of $5,625 and a weighting of 1.9%.
Latest Holdings of Kenneth Bate
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals Inc | 2024-04-02 | 1,198 | 242.25 | 290,216 |
AVEO | AVEO Pharmaceuticals Inc | 2010-03-11 | 375 | 15.00 | 5,625 |
Holding Weightings of Kenneth Bate
Kenneth Bate Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Bate has made a total of 1 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 32,489 shares on April 2, 2024, which brought Kenneth Bate around $8 Million.
According to the SEC Form 4 filings, Kenneth Bate has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the sale of 0 shares on March 11, 2010, which brought Kenneth Bate around $0.
Insider Trading History of Kenneth Bate
- 1
Kenneth Bate Trading Performance
Kenneth Bate Ownership Network
Kenneth Bate Owned Company Details
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Kenneth Bate is the director of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
Kenneth Bate Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Bate. You might contact Kenneth Bate via mailing address: C/o Millennium Pharmaceuticals Inc, 40 Landsdowne Street, Cambridge Ma 02139.